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Trientine formulations available in the UK
(as of November 2020)
• Cufence™ ─ Trientine dihydrochloride
Univar Solutions B.V. (Rotterdam, The Netherlands)
• Cuprior™ ─ Trientine tetrahydrochloride
Orphalan UK (formerly GMP Orphan) (St Albans, UK and Paris, France)
• Trientine dihydrochloride Tillomed
Tillomed Laboratories Ltd (Luton, UK) owned by Emcure (India) 
[Data from electronic medicines compendium (emc) https://www.medicines.org.uk/emc/about-the-emc Other suppliers in USA
(https://www.drugs.com/availability/generic-syprine.html) and in Europe (https://ideogen.ch/morbus-wilson-1] 
UK trientine formulations ─ SmPC information 
❑ Cufence 200 mg hard capsules trientine                  [as identified in patient leaflet]
Each size 0 hard capsule contains 300 mg trientine dihydrochloride
─  equivalent to 200 mg trientine (free base)
❑ Cuprior 150 mg film-coated tablets trientine [as identified in patient leaflet]
Each film-coated tablet contains 300 mg trientine tetrahydrochloride
─ equivalent to 150 mg trientine (free base)
❑ Trientine dihydrochloride Tillomed 250 mg hard capsules trientine dihydrochloride                        
[as identified in patient leaflet]
Each hard capsule contains 250 mg trientine dihydrochloride
─ equivalent to 167 mg trientine (free base)
Comparison of UK trientine formulationsa
❑ Size and description of formulationa
❑ Dosage form and packaginga
❑ Storage conditionsa
❑ Bioequivalence and dose equivalence data for Cufence and Cupriora,b
❑ Licensed dosea
a. See notes circulated for this meeting for more details of UK trientine formulations.
b. Lacking peer-reviewed data in the scientific literature.
Trientine dose equivalents ─ calculations
Trientine tetrahydrochloride ─ molar mass: 292.1 grams/mole   
Trientine (free base) ─ molar mass:146.2 grams/mole  




i.e. 219.2 g trientine•2HCl ≡ 146.2 g trientine free base ≡ 292.1 g trientine•4HCl 
∴ ONE 300 mg trientine•2HCl capsule ≡ 200 mg trientine free base 
∴ ONE 300 mg trientine•4HCl tablet ≡ 150 mg trientine free base 
Cost of Cuprior in the UK*
❑ Reported cost for a one year supply of Cuprior per patient = £40,000
❑ For a patient on 4 x 150 mg Cuprior tablets daily, one year’s supply = 219 g trientine base
❑ Technical grade (70%) trientine base = £4.2/1000 g*, i.e. 219 g = £0.92
❑ Percentage markup = [(sales price ‒ unit cost) / unit cost] x 100%
❑ i.e. [(£40,000 ‒ £0.92) / £0.92] x 100 = 4.4 x 106 per cent; 4.4 million per cent markup
* Data from Alibaba website, November 2020
https://www.alibaba.com/product-detail/Hot-Sale-Industry-Grade-Triethylenetetramine-With_62300282876.html?spm=a2700.7724857.normalList.48.42831fcbePOtpO
* Similar arithmetic would apply to Cufence.
Comments on Tillomed’s trientine dihydrochloride
❑ API is manufactured by Emcure, Pune, India.
❑ Probably a different manufacturing route than that used for Cufence and Cuprior 
(patent data).
❑ Questionable claim for stability in Tillomed’s Summary of Product Characteristics:
“This medicinal product does not require any special temperature storage  
conditions.”
❑ FDA has issued a number of Warning Letters after inspections of Emcure’s Pune 
manufacturing facilities.
